Cargando…
Schistosomiasis, hepatitis B and hepatitis C co-infection
BACKGROUND: Schistosomiasis is a significant health problem in more than 70 countries distributed between Africa, Asia and South America, with an infection rate of one in 30 individuals. Data on Schistosomiasis, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) co-infection are scarce; however, th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323254/ https://www.ncbi.nlm.nih.gov/pubmed/25889398 http://dx.doi.org/10.1186/s12985-015-0251-2 |
_version_ | 1782356517529321472 |
---|---|
author | Gasim, Gasim I Bella, Abdelhaleem Adam, Ishag |
author_facet | Gasim, Gasim I Bella, Abdelhaleem Adam, Ishag |
author_sort | Gasim, Gasim I |
collection | PubMed |
description | BACKGROUND: Schistosomiasis is a significant health problem in more than 70 countries distributed between Africa, Asia and South America, with an infection rate of one in 30 individuals. Data on Schistosomiasis, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) co-infection are scarce; however, there is a high prevalence in countries where schistosomiasis is endemic. METHODS: A systematic search was performed on published data from 1980–2014. Published papers in the databases Google, Medline, PubMed, and MiPc library were searched using the keywords epidemiology, pathogenesis and outcomes of HBV, HCV and schistosomiasis and data were extracted from the relevant studies. RESULTS: The prevalence of HBV/schistosomiasis co-infection in countries where schistosomiasis is endemic was high, ranging between 9.6 to approximately 64% in Egypt, and a maximum of 15.8% among hospitalized patients in Brazil. Concurrent infection between HBV and schistosomiasis is often associated with countries where schistosomiasis is endemic and may lead to chronic liver inflammation. Similarly, HCV infection rates in schistosomiasis populations range from 1% in Ethiopia reaching up to 50% in Egypt. CONCLUSION: There is controversy regarding the effects of HBV and HCV on schistosomiasis and vice versa. Vaccination might be a solution to the era of schistosomiasis and co-infection with HBV and HCV. |
format | Online Article Text |
id | pubmed-4323254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43232542015-02-11 Schistosomiasis, hepatitis B and hepatitis C co-infection Gasim, Gasim I Bella, Abdelhaleem Adam, Ishag Virol J Review BACKGROUND: Schistosomiasis is a significant health problem in more than 70 countries distributed between Africa, Asia and South America, with an infection rate of one in 30 individuals. Data on Schistosomiasis, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) co-infection are scarce; however, there is a high prevalence in countries where schistosomiasis is endemic. METHODS: A systematic search was performed on published data from 1980–2014. Published papers in the databases Google, Medline, PubMed, and MiPc library were searched using the keywords epidemiology, pathogenesis and outcomes of HBV, HCV and schistosomiasis and data were extracted from the relevant studies. RESULTS: The prevalence of HBV/schistosomiasis co-infection in countries where schistosomiasis is endemic was high, ranging between 9.6 to approximately 64% in Egypt, and a maximum of 15.8% among hospitalized patients in Brazil. Concurrent infection between HBV and schistosomiasis is often associated with countries where schistosomiasis is endemic and may lead to chronic liver inflammation. Similarly, HCV infection rates in schistosomiasis populations range from 1% in Ethiopia reaching up to 50% in Egypt. CONCLUSION: There is controversy regarding the effects of HBV and HCV on schistosomiasis and vice versa. Vaccination might be a solution to the era of schistosomiasis and co-infection with HBV and HCV. BioMed Central 2015-02-08 /pmc/articles/PMC4323254/ /pubmed/25889398 http://dx.doi.org/10.1186/s12985-015-0251-2 Text en © Gasim et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Gasim, Gasim I Bella, Abdelhaleem Adam, Ishag Schistosomiasis, hepatitis B and hepatitis C co-infection |
title | Schistosomiasis, hepatitis B and hepatitis C co-infection |
title_full | Schistosomiasis, hepatitis B and hepatitis C co-infection |
title_fullStr | Schistosomiasis, hepatitis B and hepatitis C co-infection |
title_full_unstemmed | Schistosomiasis, hepatitis B and hepatitis C co-infection |
title_short | Schistosomiasis, hepatitis B and hepatitis C co-infection |
title_sort | schistosomiasis, hepatitis b and hepatitis c co-infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323254/ https://www.ncbi.nlm.nih.gov/pubmed/25889398 http://dx.doi.org/10.1186/s12985-015-0251-2 |
work_keys_str_mv | AT gasimgasimi schistosomiasishepatitisbandhepatitisccoinfection AT bellaabdelhaleem schistosomiasishepatitisbandhepatitisccoinfection AT adamishag schistosomiasishepatitisbandhepatitisccoinfection |